Konstantin C. Zouboulis

Konstantin C. Zouboulis

Auto-generated profile, based on publicly available information

Konstantin C. Zouboulis

Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2025 in Nature Methods
Verified
Journal Article
Open access
PDF file
JBJack L. Bennett
Jack L. Bennett
TETarick J. El-Baba
Tarick J. El-Baba
KZKonstantin C. Zouboulis
Konstantin C. Zouboulis
CKCarla Kirschbaum
Carla Kirschbaum
HSHaigang Song
Haigang Song
CRCarol V. Robinson
Carol V. Robinson
Protein modifications drive dynamic cellular processes by modulating biomolecular interactions, yet capturing these modifications within their native structural context remains a significant challenge. Native top-down mass spectrometry promises to preserve the critical link between modifications and interactions. However, current methods often fail to detect uncharacterized or low-abundance modifications, limiting insights into proteoform diversity. To address this gap, we introduce precise and accurate Identification Of Native proteoforms (precisION), an interactive end-to-end software package that leverages a robust, data-driven fragment-level open search to detect, localize and quantify ‘hidden’ modifications within intact protein complexes. Applying precisION to four therapeutically relevant targets—PDE6, ACE2, osteopontin (SPP1) and a GABA transporter (GAT1)—we discover undocumented phosphorylation, glycosylation and lipidation, and resolve previously uninterpretable density in an electron cryo-microscopy map of GAT1. As an open-source software package, precisION offers an intuitive means for interpreting complex protein fragmentation data. This tool will empower the community to unlock the potential of native top-down mass spectrometry, advancing integrative structural biology, molecular pathology and drug development.

8 May 2025 in Science
Verified
Journal Article
Closed access
XZXin Zhu
Xin Zhu
TBTimothy J. D. Bennett
Timothy J. D. Bennett
KZKonstantin C. Zouboulis
Konstantin C. Zouboulis
DSDimitrios Soulias
Dimitrios Soulias
MGMichal Grzybek
Michal Grzybek
MKMadhavi Krishnan
Madhavi Krishnan
Size and shape are critical discriminators between molecular species and states. We describe a microchip-based high-throughput imaging approach offering rapid and precise determination of molecular properties under native solution conditions. Our method detects differences in molecular weight across at least three orders of magnitude and down to two carbon atoms in small molecules. We quantify the strength of molecular interactions across more than six orders of magnitude in affinity constant and track reactions in real time. Highly parallel measurements on individual molecules serve to characterize sample-state heterogeneity at the highest resolution, offering predictive input to model three-dimensional structure. We further leverage the method’s structural sensitivity for diagnostics, exploiting ligand-induced conformational changes in the insulin receptor to sense insulin concentration in serum at the subnanoliter and subzeptomole scale.

3 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DLDan Loewenthal
Dan Loewenthal
RARoi Asor
Roi Asor
STStephen Thorpe
Stephen Thorpe
JPJack S. Peters
Jack S. Peters
KZKonstantin C Zouboulis
Konstantin C Zouboulis
PKPhilipp Kukura
Philipp Kukura
The dynamic choreography of biomolecular interactions underpins the processes of life, but its direct observation remains challenging. Here, we introduce confined diffusion mass photometry, enabling hour-long, mass-resolved observation of individual biomolecules, their complexes and interactions with up to sub-kDa mass precision and ms temporal resolution. Our approach represents a quantitative time-resolved single-molecule measurement modality for studying complex biomolecular mechanisms in action.

10 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SHSeham Helmi
Seham Helmi
RARoi Asor
Roi Asor
MMMaya Miller
Maya Miller
JTJan Christoph Thiele
Jan Christoph Thiele
DWDi Wu
Di Wu
PKPhilipp Kukura
Philipp Kukura
Proteins exist in diverse biochemical states, including oligomers, complexes, heterogeneous proteoforms and shed fragments that encode functional and regulatory information. Yet, these molecular states remain difficult to resolve with existing analytical techniques, which typically require labelling, immobilisation or amplification and collapse this information into a single readout. Here, we introduce a modular platform that integrates programmable DNA nanostructures with single-molecule mass photometry for rapid, label-free and multiplexed protein analysis in native and complex media, without washing, enrichment or immobilisation, making native biochemical states observable directly in serum and plasma. DNA nanostructures act as nanosensors whose mass and mobility on supported lipid bilayers provide orthogonal identifiers for target identity and biochemical state, thereby decoupling recognition from readout. We define the analytical specificity and response window, demonstrate quantitative affinity determination, and resolve oligomeric and proteoform differences under native conditions. The nanosensors are rapidly reprogrammable to new targets, support multiplexed detection with internal controls for non-specific interactions, and enable selective resetting via strand displacement. Together, these capabilities establish nanoscale programmability as a route to state-resolved single-molecule protein profiling adaptable to both diagnostic and mechanistic applications.

10 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
KZKonstantin C. Zouboulis
Konstantin C. Zouboulis
JBJack L. Bennett
Jack L. Bennett
LDLeonard A. Daly
Leonard A. Daly
SBSean A. Burnap
Sean A. Burnap
EHEllie Holden
Ellie Holden
JBJustin L.P. Benesch
Justin L.P. Benesch
O-glycosylation is among the most abundant and structurally diverse post-translational modifications in eukaryotes, yet its heterogeneity renders O-glycoproteins exceptionally difficult to characterize. To overcome these challenges, we have developed an integrated mass spectrometry (MS) strategy to define the proteoform landscape of O-glycoproteins and applied it to human osteopontin (OPN). OPN is a disease-associated extracellular matrix protein subject to extensive modification. By combining native MS with serial exoglycosidase digestions, we directly resolved truncation, phosphorylation, sulfation, and O-glycosylation of OPN. Matched glycoproteomic analyses, using tailored (glyco)protease combinations, allowed us to quantify glycan heterogeneity inaccessible to conventional trypsin-based approaches or protein-centric methods. We integrated these datasets using forward compositional simulations to infer the intact OPN proteoform distribution and benchmarked the resulting models against an experimental intact-mass distribution obtained by proton-transfer charge-reduction MS. This comparison revealed that bottom-up O-glycoproteomics systematically underestimates the true extent of glycan sialylation, whereas assuming (near-)complete sialylation accurately reproduced the experimental intact OPN mass distribution. Together, these results provide a comprehensive, quantitative view of OPN compositional diversity and demonstrate how intact-protein and peptide-level measurements can be reconciled to resolve highly heterogeneous glycoform populations. The workflow establishes a broadly applicable framework for characterizing extensively O-glycosylated and multiply modified proteins.

28 August 2026 in Insights in Biochemistry and Molecular Biology
Verified
Journal Article
Open access
YWYicheng Wang
Yicheng Wang
EBEleanor Bogie
Eleanor Bogie
ATAnthony Tumber
Anthony Tumber
KZKonstantin C. Zouboulis
Konstantin C. Zouboulis
ESEidarus Salah
Eidarus Salah
LBLennart Brewitz
Lennart Brewitz